Product Images Nypozi
View Photos of Packaging, Labels & Appearance
- 300mcg (1) 0.5 mL Syringe Carton. - 300mcg (1) 0.5 mL Syringe Carton
- 300mcg (10) 0.5 mL Syringe Carton. - 300mcg (10) 0.5 mL Syringe Carton
- 480mcg (1) 0.8 mL Syringe Carton. - 480mcg (1) 0.8 mL Syringe Carton
- 480mcg (10) 0.8 mL Syringe Carton. - 480mcg (10) 0.8 mL Syringe Carton
- Cipla Logo. - Cipla Logo
- nypozi-01. - nypozi 01
- nypozi-02. - nypozi 02
- nypozi-03. - nypozi 03
- nypozi-04. - nypozi 04
- nypozi-05. - nypozi 05
- nypozi-06. - nypozi 06
- nypozi-07. - nypozi 07
- nypozi-08. - nypozi 08
- nypozi-09. - nypozi 09
- nypozi-10. - nypozi 10
- nypozi-11. - nypozi 11
- nypozi-12. - nypozi 12
- nypozi-13. - nypozi 13
- nypozi-14. - nypozi 14
- nypozi-15. - nypozi 15
- nypozi-16. - nypozi 16
- nypozi-17. - nypozi 17
Product Label Images
The following 22 images provide visual information about the product associated with Nypozi NDC 69097-430 by Cipla Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
300mcg (1) 0.5 mL Syringe Carton. - 300mcg (1) 0.5 mL Syringe Carton
This text appears to be a description of a pharmaceutical product called NYPOZI™ Single-Dose Prefilled Syringe, which contains the medication filgrastim-txid in the form of an injection. The product is a Recombinant Granulocyte Colony Stimulating Factor derived from E. Coli, intended for subcutaneous or intravenous use. Instructions are given on how to dilute the medication for intravenous administration and under what conditions the product should be stored. The manufacturer is Tanvex BioPharma USA, Inc. from San Diego, CA. The product is indicated to be refrigerated and kept away from light. It is also mentioned to be kept out of reach of children.*
480mcg (1) 0.8 mL Syringe Carton. - 480mcg (1) 0.8 mL Syringe Carton
This text provides information about a single-dose prefilled syringe named NYPOZI™ containing filgrastim-txid injection with a concentration of 480 mcg/0.8 mL. It is a recombinant Granulocyte Colony Stimulating Factor (G-CSF) derived from E. Coli and is recommended for subcutaneous or intravenous use. For intravenous administration, it should be diluted in 5% Dextrose Injection, and if needed, Albumin (Human) should be added. The syringe should be discarded after use. The product does not contain latex, and it is stored refrigerated between 2 to 8 degrees Celsius. The text also mentions the manufacturer Cipla and provides contact information. It emphasizes keeping the drug out of reach of children and includes dosing information.*
nypozi-01. - nypozi 01
This text seems to be describing the components and instructions for using a medical product, likely a syringe. It includes details such as the viewing window, expiration date label, needle guard, finger grips, plunger, dose markings, and instructions for before and after use. This information may be helpful for understanding how to properly operate and maintain the syringe.*
nypozi-05. - nypozi 05
This is a list of medical supplies that includes alcohol wipes, adhesive bandages, and a disposal container. The alcohol wipes can be used for cleaning wounds, while adhesive bandages are used to cover small cuts or injuries. The disposal container is likely for safe disposal of used medical supplies.*
nypozi-10. - nypozi 10
This text seems to describe a step-by-step process for setting a partial dose. It includes instructions for the initial position and aligning the plunger stopper for the dose.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.